December 27, 2014 12:16 PM ET

Healthcare Equipment and Supplies

Company Overview of Cervel Neurotech, Inc.

Company Overview

Cervel Neurotech, Inc., a medical device company, develops a technology to non-invasive deep brain neuro-modulation. It develops Cervel System for the non-invasive deep brain stimulation of cortical and subcortical structures for the treatment of psychiatric and neurologic disorders. The company’s repetitive transcranial magnetic stimulation uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. Cervel Neurotech, Inc. was formerly known as NeoStim, Inc. The company was founded in 2008 and is based in Redwood City, California.

3698 Haven Avenue

Suite A

Redwood City, CA 94063

United States

Founded in 2008

Phone:

650-295-0820

Fax:

650-295-0821

Key Executives for Cervel Neurotech, Inc.

Chief Executive Officer
Executive Officer and Director
Compensation as of Fiscal Year 2014.

Cervel Neurotech, Inc. Key Developments

Cervel Neurotech, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 02:30 PM

Cervel Neurotech, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 02:30 PM. Venue: The Ritz Carlton, 10 Avery St., Boston, Massachusetts, United States. Speakers: Eric Meier, President and CEO.

Cervel Neurotech, Inc. Signs Master Research Agreement with Neuroscience Center

Cervel Neurotech, Inc. announced the formation of a Master Research Agreement with the Danish Neuroscience Center at Aarhus University Hospital in Aarhus, Denmark. The agreement represents the first Cervel System placement into the European Union (EU) and initiates investigation of a second clinical indication, the treatment of chronic pain, using Cervel's multicoil repetitive transcranial magnetic stimulation (rTMS) technology. The five-year agreement provides the basis for a series of research protocols designed to reveal insights into the mechanisms underlying brain stimulation and pain perception, with the objective of developing new treatments for patients resistant to traditional pharmaceutical therapy. The first study aims to establish the safety and efficacy of the Cervel System for patients suffering from chronic neuropathic pain.

Cervel Neurotech, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014

Cervel Neurotech, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014 . Venue: Westin San Francisco Market Street, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
Neurolutions Inc. United States
Smiths Medical ASD, Inc. United States
Scion NeuroStim, LLC United States
LIM innovations Inc. United States
emed Incorporated United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 17, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cervel Neurotech, Inc., please visit www.cervel.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.